Industry News
Minghui Pharmaceutical Announces Promising Initial Results from Phase I Clinical Trial of MHB039A, a Novel PD-1 x VEGF Bispecific Antibody, in Patients with Relapsed/Refractory Solid Tumors
SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company focused on developing transformative medicines in immunology and oncology, today announced initial results from its Phase I clinical trial of MHB039A, a novel PD-1 x VEGF bispecific antibod...
2024-11-06 18:00
2963
Dingdong (Cayman) Limited Announces Third Quarter 2024 Financial Results
SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company inChina, with advanced supply chain capabilities, today announced its unaudited financial results for the quarter endedSeptember 30, 2024. Third ...
2024-11-06 18:00
1311
Autohome Inc. Announces Unaudited Third Quarter 2024 Financial Results
BEIJING, Nov. 6, 2024 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers inChina, today announced its unaudited financial results for the three months endedSeptember 30, 2024. Third Quarter 2024 Highlights...
2024-11-06 17:30
1393
CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING
LONDON, Nov. 6, 2024 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories company and leading innovator in the dermatologic and aesthetics industry, is proud to announce that Cavendish Clinics, one of theUnited Kingdom's ("UK") premier aesthetic clinic groups, has upgraded their microneedling d...
2024-11-06 17:00
1279
ATFX Wins Two Awards at the 2024 International Investor Awards
HONG KONG, Nov. 6, 2024 /PRNewswire/ -- ATFX is proud to announce its achievement of two esteemed awards at the 2024 International Investor Awards, reinforcing its position as a leader in the global forex trading sector. The company was awarded"Best Global Forex Broker 2024", a testament to its ...
2024-11-06 17:00
1295
Straits Financial Services Pte Ltd Successfully Participated First Trades of CME Group's Spodumene Futures
SINGAPORE, Nov. 6, 2024 /PRNewswire/ -- Straits Financial Services Pte Ltd (SFSPL) has successfully participated in the launch of CME Group's Spodumene CIF China (Fastmarkets) Futures. The launch of Spodumene futures is due to the rising global demand for lithium, which has emerged as an indispen...
2024-11-06 17:00
1333
Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Third Quarter of 2024
TAIPEI, Nov. 6, 2024 /PRNewswire/ -- Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) ("Chunghwa" or "the Company") today reported its un-audited operating results for the third quarter of 2024. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards ("T...
2024-11-06 16:55
1282
The 136th Canton Fair Advances High-Quality Development of International Trade with Overseas Buyers Attendance Hitting Record Numbers
GUANGZHOU, China, Nov. 6, 2024 /PRNewswire/ -- The 136th Canton Fair has concluded successfully, with the number of overseas buyers hitting a record high. The event significantly promoted high-quality development of international trade and further expandedChina's opening up to the global market. ...
2024-11-06 16:49
1376
CNOOC Limited Brings On-stream Long Lake NW Project in Canada
HONG KONG, Nov. 6, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that Long Lake Northwest Project inCanada has commenced production safely. The project is located in Alberta, Canada. The main production facilities i...
2024-11-06 16:43
1469
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the latest results...
2024-11-06 16:09
1430
Thailand announces 2025 as the "Amazing Thailand Grand Tourism and Sports Year"
At WTM 2024, Thailand's Tourism and Sports Minister reveals 2025 tourism agenda with new attractions, cultural celebrations, and global collaboration to bolster the tourism sector. LONDON, Nov. 6, 2024 /PRNewswire/ -- Thailand's Minister of Tourism and Sports, Mr. Sorawong Thienthong, announced ...
2024-11-06 16:07
1617
GTI Initiates Global Recruitment for Intelligent RAN, Ubiquitous AI Project of 5G-A×AI Development Program
ISTANBUL, Nov. 6, 2024 /PRNewswire/ -- At the Global MBB Forum 2024 (MBBF 2024), GTI kicked off the global recruitment for the Intelligent RAN, Ubiquitous AI Project, aimed at accelerating the two-way empowerment between 5G-A and AI in its 5G-A×AI Development Program. There was a discussion on th...
2024-11-06 16:02
1474
ATRenew to Report Third Quarter 2024 Financial Results on November 20, 2024
SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform in China, today announced that it plans to release its unaudited financial results for the third quarter of ...
2024-11-06 16:00
1172
Volta Energy Solutions Hungary pursues 'The Copper Mark' award
* The "Copper Mark" is the leading assurance framework to promote responsible practices across the copper industry that considers the environmental, social and governance issues, from mining to processing, in the copper industry. * CEO Kwak Keun-man said, "We will prove that our sourcing is et...
2024-11-06 16:00
835
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that multiple studies o...
2024-11-06 15:56
1615
Xinhua Silk Road: Yangtze River culture and art season wraps up in C. China Hubei Yichang
BEIJING, Nov. 6, 2024 /PRNewswire/ -- The Yangtze River Cultural and Artistic
Season officially wrapped up on Monday with closing ceremony held in Yichang
City, centralChina's Hubei Province.
2024-11-06 15:54
1240
Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss
Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeek High Quality Obesity Management by Targeting the CRF2 Receptor: Enhanced Fat Loss with Lean Mass Increase Improved Weight Loss and Muscle Preservation with HM15275 Comb...
2024-11-06 15:41
1057
Crowne Plaza Phu Quoc Starbay Invites Travelers to Create Memorable Journey on One of the World's Most Beautiful Islands
PHU QUOC, Vietnam, Nov. 6, 2024 /PRNewswire/ -- Crowne Plaza Phu Quoc Starbay
2024-11-06 15:36
1415
ASEAN FinTech funding grew more than 10-fold in past decade, GenAI and Quantum Computing to power new era: FinTech in ASEAN 2024 report
Optimism in ASEAN's FinTech scene as Singapore and Thailand draw top funding this year. SINGAPORE, Nov. 6, 2024 /PRNewswire/ -- Funding for Financial Technology (FinTech) in ASEAN has surged more than 10 times since 2015[1], growing at an exponential rate compared to global FinTech funding. This...
2024-11-06 15:31
5962
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
NANJING, China, Nov. 6, 2024 /PRNewswire/ -- On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which is independently developed by Leads Biolabs with glo...
2024-11-06 15:20
1213
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9273
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7751